Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin for Pain Relief in Post-Herpetic Neuralgia
NCT00159666Phase 4Completed
- Sponsor
- Viatris
- Start
- Oct 2004
- Modality
- Small Molecules
- Countries
- 5
01
Overview
Phase 4, randomised, double-blind trial of pregabalin in postherpetic neuralgia (PHN) (3 arms), sponsored by Viatris. Primary endpoint: Onset meaningful pain reduction. Started Oct 2004; status: completed.
02
Drugs
pregabalin
03
Conditions
postherpetic neuralgia (PHN)
Beyond the preview
Go deeper on NCT00159666.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00159666.